Subramanian Sankar, Senior VP, Product Development at Nautilus Biotechnology, Inc. (NAUT), bought 15,000 shares at $2.03 ($30K) on 2022-09-26, disclosed to the SEC on 2022-09-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.03 | 10,000 | $20K | 66.7% |
| 2 | $2.03 | 5,000 | $10K | 33.3% |
| Total | $2.03 avg | 15,000 | $30K | 100% |